BPC
SGMO

Banque Pictet & Cie’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Banque Pictet & Cie’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-85,944
Closed -$151K – 592
2023
Q1 		$151K Sell
85,944
-38,966
-31% -$111K ﹤0.01% 557
2022
Q4 		$392K Sell
124,910
-39,412
-24% -$153K ﹤0.01% 536
2022
Q3 		$805K Sell
164,322
-613
-0.4% -$3.15K 0.01% 427
2022
Q2 		$683 Sell
164,935
-15,896
-9% -$68.7K 0.01% 481
2022
Q1 		$1.05M Buy
180,831
+6,999
+4% +$41.6K 0.01% 437
2021
Q4 		$1.3M Buy
+173,832
New +$1.51M 0.01% 421

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Banque Pictet & Cie's SGMO Position: Q2 2023 in Review

Banque Pictet & Cie sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2023, closing a stake of 85,944 shares — an estimated $151K sold.

Banque Pictet & Cie first reported a position in SGMO in Q4 2021 and held it in 6 quarters. The position peaked at $1.3M in Q4 2021. 152 funds tracked by Wall St. Rank hold SGMO as of Q2 2023.

  • Banque Pictet & Cie reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2023 after selling out during the quarter.
  • Banque Pictet & Cie sold 85,944 SANGAMO THERAPEUTICS INC shares in Q2 2023, an estimated $151K.
  • Banque Pictet & Cie first reported a position in SANGAMO THERAPEUTICS INC in Q4 2021 and held it in 6 quarters.
  • Banque Pictet & Cie's SANGAMO THERAPEUTICS INC position peaked at $1.3M in Q4 2021.
  • 152 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2023.

Based on Banque Pictet & Cie's 13F filing for Q2 2023, filed 4 Aug 2023.